miRNAs Participate in MS Pathological Processes and Its Therapeutic Response

Table 1

MiRNA biomarkers of therapeutic response in multiple sclerosis (MS).

Drug treatment	Increased miRNA	Decreased miRNA
NatalizumAb	miR-18a, 20b, 29a, 103	miR-326, 17
INF-β	miR-26-5p, 16-5p, 342-5p, 346, 518b, 760, let-7a-5p, 7b-5p	miR-27a-5p, 29a-3p, 29b-1-5p, 29c-3p, -95, 149-5p, 181c-3p, 193a-3p, -193-5p, 423-5p, 532-5p, 708-5p, 874
GA		miR-146a, miR-142-3p
GSK3β inhibitors		miR-98 and let-7g